Injective (INJ) is a decentralized smart contract platform built to support decentralized finance (DeFi) applications, specializing in fast and low-cost transactions. Powered by Cosmos and Ethereum, Injective enables a highly interoperable and customizable blockchain solution with a focus on DeFi. Its unique Proof of Stake consensus mechanism provides security while supporting sustainable scalability. Injective’s decentralized order book, cross-chain capability, and composability make it a powerful tool for developers and users alike in the DeFi space. Known for its speed and efficiency, Injective appeals to users and institutions looking to access decentralized markets without high fees or intermediaries. With its open-source structure, Injective's platform allows for a range of DeFi applications, such as spot trading, derivatives, and synthetic assets. Users can buy, sell, and trade Injective on various exchanges, with live market data, historical trends, and analytics available on our Injective Markets page to help you stay informed on the latest trends and updates in the DeFi space.
Polymarket gives Anthropic's IPO a 66% chance of a $2T first-day close as Nvidia weighs a $10B anchor stake.
The XRP Ledger set a transaction record of 3,254 in one ledger, but onchain data shows 20 wallets sent 2,000 identical 1-drop payments.
Discover how Zamanat Fund CEIC Limited is addressing the $250 billion SME financing gap in the GCC through innovative tokenization.
A STONK trader who bought near a $1M market cap realized $327,436 after a hack and a 30-day round trip, while the bitcoin price holds near $77,500.
Ripple's RLUSD supply hit a record $2.44B, but Ethereum now holds $1.37B versus $1.05B on the XRP Ledger
